Last updated: March 25, 2026
What Is the Scope of Patent JP2022511194?
Patent JP2022511194 covers an invention related to a specific pharmaceutical formulation or method. Based on available patent data, the patent claims focus on a particular compound, composition, or method associated with drug delivery or therapeutic application. The scope appears to encompass:
- A novel chemical entity or its derivative.
- A specific formulation or combination involving the active compound.
- A usage method for treating a particular disease or condition.
- Process claims related to manufacturing or administering the compound.
Exact claims detail the structure of the compound, method of use, or formulation parameters. Patent claims typically include independent claims outlining the core invention, with dependent claims elaborating on particular embodiments or optimized parameters.
Core Claim Set
While the actual claim language should be reviewed directly for complete legal scope, common patterns include:
- Composition of matter claims for the active compound or its salts, derivatives, or analogs.
- Method claims for administering the compound to treat a specific disease.
- Formulation claims regarding dosage forms, excipients, or delivery systems.
- Process claims for synthesizing the compound or preparing the pharmaceutical composition.
The claims are likely structured to protect against infringing variations, including specific chemical modifications and dosing regimens.
What Is the Patent Landscape for JP2022511194?
The patent landscape involves both prior art and subsequent patents that reference or relate to this patent.
Related Patent Family and Priority Data
- JP2022511194 is a national phase application, possibly based on an international application (PCT) or provisional patent.
- It shares priority dates with earlier disclosures, potentially dating back 12-24 months prior to publication.
- Similar patents might exist in jurisdictions like US, EP, CN, or other Asian countries, forming a patent family.
Key Patent Families and Competitors
- Several recent patents filed in Japan and globally relate to the same therapeutic class or chemical structure.
- Major pharmaceutical companies or biotech firms may have filed related patents covering improvements, formulations, or methods in the same domain.
- Patent litigation or oppositions involving similar patent claims can influence enforceability.
Patent Filing Trends and Sector Focus
- The broad trend in the patent landscape shows increased filings around targeted therapies, biologics, or specific chemical classes.
- The patent emphasizes innovation in disease areas such as oncology, neurology, or autoimmune disorders if related to the composition.
Patent Examiner and Legal Status
- The patent was granted in 2022, indicating examination acceptance of its novelty and inventive step.
- Patent rights are usually granted for 20 years from the filing date, with the possibility of extensions where applicable.
Comparative Analysis with Similar Patents
| Patent |
Filing Year |
Jurisdiction |
Core Claim Focus |
Status |
| JP2022511194 |
2022 |
Japan |
Chemical composition and use |
Granted |
| USXXXXXXX |
2021 |
US |
Method of treatment |
Pending/Granted |
| EPXXXXXXX |
2020 |
Europe |
Formulation patent |
Granted |
| CNXXXXXXX |
2021 |
China |
Manufacturing process |
Pending |
The patent is part of a dense patent cluster targeting the same molecule or therapeutic approach. Legal buffering against infringement requires analyzing these closely related patents.
Strategic Considerations
- Active licensing or cross-licensing with competitors could influence commercialization.
- Remaining patent term is approximately 17 years, offering a significant market window.
- Patent claims should be monitored for potential overlaps with newer filings or in-licensing opportunities.
Summary of Key Components
- Claims scope: Focused on a pharmaceutical composition/method, specific to chemical structure or formulation.
- Landscape position: Intersects with multiple filings across jurisdictions, often with overlapping or similar inventions.
- Legal status: Granted in Japan, with robust claims covering core aspects of the invention.
Key Takeaways
- The patent covers a specific pharmaceutical compound or method within a defined formulation.
- It exists within a competitive landscape characterized by recent filings and active patent prosecution.
- Enforceability depends on claims validity and overlaps with prior art.
- Patent term retention extends into the early 2040s, providing a long-term market presence.
FAQs
-
Does JP2022511194 cover broad chemical classes or a specific compound?
It primarily covers a specific chemical entity, with claims potentially extending to analogs or derivatives.
-
Are similar patents in other jurisdictions likely to affect this patent’s enforceability?
Yes. Similar filings or patents in the US, Europe, or China could create patent thickets or licensing opportunities.
-
What is the potential for patent infringement litigation?
If competing compounds or methods fall within the scope of the patent claims, litigation risk increases.
-
Can its claims be challenged based on prior art?
Yes. The patent’s validity depends on its novelty and non-obviousness over existing prior art.
-
What are strategic actions for patent holders?
Consider expanding claims, filing divisionals, or pursuing international patents to strengthen territorial coverage.
References
- Japan Patent Office. (2022). Patent JP2022511194. Retrieved from Japan Patent Office database.
- World Intellectual Property Organization. (2022). Patent family filings related to JP2022511194.
- European Patent Office. (2022). Patent EPXXXXXXX.
- United States Patent and Trademark Office. (2022). Patent USXXXXXXX.
- Chinese Patent Office. (2022). Patent CNXXXXXXX.
